EVENT POSTPONED DUE TO COVID-19

To safeguard against COVID-19, we have taken the decision to postpone this event. We are working with the venue to schedule a new date later this year. Register your interest here to get updates.

Pursuing Disease Causation to Foster the Creation of Targeted Microbiome Based Therapeutics, Biomarkers & Diagnostics

Welcome to the 5th Microbiome Movement - Drug Development Summit 2020

The Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.

If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also to make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

Meet Our 70+ Expert Speaker Faculty

Gerard Honig

Associate Director, Research Innovation

Crohn’s & Colitis Foundation

Matthew Henn

CSO

Seres Therapeutics

Alison Lawton

CEO

Kaleido Biosciences

Dan Knights

CEO

Corebiome

Eric Shaff

CEO

Seres Therapeutics

Bernat Olle

CEO

Vedanta Biosciences

Adrien Nivoliez

CEO

Biose Industrie

Stacy Burns-Guydish

VP Biotherapeutics Development & Manufacturing

List Laboratories

Hear What Our Customers Say

"This is far and away the best of the microbiome therapeutics conferences I’ve attended. Always up to date, relevant topics, and speakers from a wide range of companies. The networking opportunities alone are fantastic”

Julius Goepp, CEO, Scaled Microbiomics

“The Microbiome Movement – Drug Development Summit is probably the most important meeting to attend for anyone involved in microbiome drug development

Julie Schwedock, CMC Associate Scientific Fellow, Takeda

Confirmed Partners for 2020 Include

Lead Partner:

Boston Analytical

Expertise Partners:

ArrantaBio-Logo
DNAgenotek_Logo_Spot
CosmosID

Other Confirmed Partners:

2778561487350159120
Biomodels-Logo-final
New-biose-industrie-002
BACTHERA_logo_RGB_black-002
main-logo
FluidAir-450x227
loop-genomics-logo
Luina-Bio-Header
renderimage
download
download
Folie3-e1563909786390
pQ1D9Bpr

Other Events In The Series